| |
| |
|
| Insider
Information: |
Krill Steven L. |
| Relationship: |
EVP & Chief Scientific... |
| City: |
Woodcliff Lake |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,280 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,000 |
|
|
| Total
Value |
$14,280 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eagle Pharmaceuticals, Inc. |
EGRX |
EVP & Chief Scientific... |
2018-01-07 |
3,000 |
2015-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2018-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2017-03-23 |
4 |
S |
$82.06 |
$576,489 |
D/D |
(7,025) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2017-03-23 |
4 |
OE |
$12.63 |
$88,807 |
D/D |
7,025 |
7,025 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2017-03-22 |
4 |
S |
$80.09 |
$568,641 |
D/D |
(7,100) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2017-03-22 |
4 |
OE |
$4.42 |
$48,517 |
D/D |
7,100 |
7,100 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-23 |
4 |
OE |
$46.09 |
$236,303 |
D/D |
5,127 |
5,127 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-23 |
4 |
S |
$78.61 |
$403,018 |
D/D |
(5,127) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-22 |
4 |
S |
$76.78 |
$393,571 |
D/D |
(5,126) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-22 |
4 |
OE |
$46.09 |
$236,257 |
D/D |
5,126 |
5,126 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-21 |
4 |
S |
$77.17 |
$791,195 |
D/D |
(10,252) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-21 |
4 |
OE |
$12.63 |
$382,742 |
D/D |
10,252 |
7,569 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-20 |
4 |
S |
$76.69 |
$766,876 |
D/D |
(10,000) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-20 |
4 |
OE |
$12.63 |
$126,300 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-19 |
4 |
S |
$75.61 |
$756,066 |
D/D |
(10,000) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-19 |
4 |
OE |
$12.63 |
$126,407 |
D/D |
10,000 |
7,317 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-15 |
4 |
S |
$74.79 |
$747,896 |
D/D |
(10,000) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-15 |
4 |
OE |
$4.42 |
$95,928 |
D/D |
10,000 |
6,270 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-13 |
4 |
S |
$73.62 |
$736,163 |
D/D |
(10,000) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-12-13 |
4 |
OE |
$4.42 |
$44,200 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-11-30 |
4 |
OE |
$4.42 |
$45,111 |
D/D |
5,787 |
1,307 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-11-30 |
4 |
S |
$80.00 |
$462,960 |
D/D |
(5,787) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-11-23 |
4 |
S |
$80.00 |
$16,000 |
D/D |
(200) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
EVP & Chief Scientific Officer |
• – – |
2016-11-23 |
4 |
OE |
$8.78 |
$1,756 |
D/D |
200 |
200 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2015-06-16 |
4 |
S |
$81.60 |
$814,368 |
D/D |
(9,980) |
0 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2015-06-16 |
4 |
OE |
$4.42 |
$81,520 |
D/D |
9,980 |
1,400 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
